Symbol Name ID |
Mef2a
myocyte enhancer factor 2A MGI:99532 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Mef2atm1.1Limm/Mef2atm1.1Limm Mef2ctm1Jjs/Mef2ctm1Jjs Tg(Cdh5-cre/ERT2)1Rha/0 involves: 129S/SvEv * 129S6/SvEvTac |
abnormal retina vasculature morphology | J:334208 |
decreased angiogenesis | J:334208 | |
Mef2atm1.1Limm/Mef2atm1.1Limm Mef2ctm2Eno/Mef2ctm2Eno Mef2dtm3Eno/Mef2dtm3Eno Tg(GFAP-cre)25Mes/0 involves: 129S/SvEv * C57BL/6 * FVB/N |
abnormal long-term potentiation | J:207812 |
decreased body weight | J:207812 | |
decreased brain size | J:207812 | |
enhanced paired-pulse facilitation | J:207812 | |
increased neuron apoptosis | J:207812 | |
normal nervous system phenotype | J:207812 | |
premature death | J:207812 | |
Mef2atm1.1Limm/Mef2atm1.1Limm Mef2dtm3Eno/Mef2dtm3Eno Tg(GFAP-cre)25Mes/0 involves: 129S/SvEv * C57BL/6 * FVB/N |
normal behavior/neurological phenotype | J:207812 |
enhanced paired-pulse facilitation | J:207812 | |
impaired coordination | J:207812 | |
normal nervous system phenotype | J:207812 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|